Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,847
datasets available to search
ShareScore release 0.9.0
Dataset results
1,847 results for “Psoriasis”
Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis
ClinicalTrials.gov study NCT00521339. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
ClinicalTrials.gov study NCT01991197. IPD Sharing: Not stated. Countries: 1. Publications: 23.
Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)
ClinicalTrials.gov study NCT03956355. IPD Sharing: NO. Countries: 2. Publications: 4.
Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis
ClinicalTrials.gov study NCT01101100. IPD Sharing: UNDECIDED. Countries: 5. Publications: 3.
A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis
ClinicalTrials.gov study NCT05600036. IPD Sharing: NO. Countries: 3. Publications: 0.
CP-690-550 Ointment For Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT01246583. IPD Sharing: YES. Countries: 2. Publications: 1.
Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis
ClinicalTrials.gov study NCT00800982. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis
ClinicalTrials.gov study NCT00267969. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Topical Diacerein in Psoriasis Vulgaris
ClinicalTrials.gov study NCT07352306. IPD Sharing: UNDECIDED. Countries: 1. Publications: 8.
A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Patients With Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT03010527. IPD Sharing: Not stated. Countries: 6. Publications: 2.
A Study to Evaluate CNTO 1959 in the Treatment of Patients With Moderate to Severe Plaque-type Psoriasis
ClinicalTrials.gov study NCT01483599. IPD Sharing: Not stated. Countries: 5. Publications: 2.
Adherence in Topical Treatment of Psoriasis
ClinicalTrials.gov study NCT02858713. IPD Sharing: NO. Countries: 1. Publications: 2.
Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis
ClinicalTrials.gov study NCT02905331. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab
ClinicalTrials.gov study NCT01543204. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)
ClinicalTrials.gov study NCT01597245. IPD Sharing: YES. Countries: 12. Publications: 11.
A Study of Efalizumab in Participants With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies
ClinicalTrials.gov study NCT00249808. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis
ClinicalTrials.gov study NCT01815424. IPD Sharing: YES. Countries: 3. Publications: 1.
A Study of Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03364309. IPD Sharing: YES. Countries: 1. Publications: 2.
Improvement of Psoriasis Patients' Adherence to Topical Drugs
ClinicalTrials.gov study NCT04220554. IPD Sharing: NO. Countries: 1. Publications: 3.
A Study of the Early Activity of Ixekizumab (LY2439821) in Moderate-to-Severe Psoriasis
ClinicalTrials.gov study NCT02387801. IPD Sharing: YES. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.